Amalgamated Bank Tyra Biosciences, Inc. Transaction History
Amalgamated Bank
- $12.1 Billion
- Q3 2024
A detailed history of Amalgamated Bank transactions in Tyra Biosciences, Inc. stock. As of the latest transaction made, Amalgamated Bank holds 424 shares of TYRA stock, worth $6,860. This represents 0.0% of its overall portfolio holdings.
Number of Shares
424
Previous 424
-0.0%
Holding current value
$6,860
Previous $7,000
42.86%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding TYRA
# of Institutions
99Shares Held
43.2MCall Options Held
353KPut Options Held
1.1K-
Ra Capital Management, L.P. Boston, MA10.4MShares$169 Million3.41% of portfolio
-
Boxer Capital, LLC San Diego, CA6.45MShares$104 Million8.05% of portfolio
-
Bvf Inc San Francisco, CA4.66MShares$75.4 Million3.48% of portfolio
-
Canaan Partners Xi LLC Menlo Park, CA4.18MShares$67.6 Million97.27% of portfolio
-
Nextech Invest Ag4.06MShares$65.6 Million15.55% of portfolio
About Tyra Biosciences, Inc.
- Ticker TYRA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 41,973,600
- Market Cap $679M
- Description
- Tyra Biosciences, Inc., a preclinical-stage biopharmaceutical company, focuses on developing therapies to overcome tumor resistance and enhance outcomes for patients with cancer. Its lead product candidate is TYRA-300, a selective inhibitor of fibroblast growth factor receptor (FGFR)3 for the treatment of muscle invasive bladder cancer. The comp...